NICE - Endorsed Clinical Guidelines 2022/2023
It is important to note that the advice contained within the guidance does not override or replace the individual responsibility of health professionals to make appropriate decisions in the circumstances of their individual patients, in consultation with the patient and/or guardian or carer.
This would, for example, include situations where individual patients have other conditions or complications that need to be taken into account in determining whether the NICE guidance is fully appropriate in their case. Clinical guidelines frequently make reference to specific legislation and guidance that do not apply in Northern Ireland. All clinical guidelines should be read taking these differences into consideration. The following NICE clinical guidelines have been endorsed during 2022/23
Clinical Guidelines
Fully Endorsed
February 2023
NG230 - Thyroid cancer: assessment and management
NG229 - Fetal monitoring in labour
‘Note this guidance partially replaces NICE Clinical Guideline CG190, endorsed by the DoH in January 2015.’
January 2023
NG228 - Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management
NG226 - Osteoarthritis in over 16s: diagnosis and management
‘Note this guidance updates and replaces NICE Clinical Guideline CG177, which was endorsed by the DoH in April 2014.’
NG225 - Self-harm: assessment, management and preventing recurrence
‘Note this guidance updates and replaces NICE Clinical Guidelines CG16 and 133, which were endorsed by the DoH in January 2012.’
October 2022
NG224 - Urinary tract infection in under 16s: diagnosis and management
'Note this guidance updates and replaces NICE Clinical Guideline CG54, which was endorsed by the DoH in October 2010'
NG222 - Depression in adults: treatment and management - Note this guidance updates and replaces NICE Clinical Guideline CG90, which was endorsed by the DoH in September 2010
NG217 - Epilepsies in children, young people and adults
‘Note this guidance updates and replaces NICE Clinical Guideline CG137, which was endorsed by the DoH in March 2012.’
September 2022
NG220 - Multiple sclerosis in adults: management
‘Note this guidance updates and replaces NICE Clinical Guideline CG186, which was endorsed by the DoH in November 2014’
August 2022
NG219 - Gout: diagnosis and management
‘Note this guidance updates and replaces NICE Technology Appraisal TA164, which was endorsed by the DoH in April 2009’
July 2022
NG215 - Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults
May 2022
NG197 - Shared decision making
NG211 - Rehabilitation after traumatic injury